BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,622,500 | -28.4% | 5,850,000 | -41.5% | 1.02% | -3.3% |
| Q2 2023 | $7,848,611 | +5.0% | 10,000,000 | 0.0% | 1.06% | +6.0% |
| Q1 2023 | $7,473,611 | +61.6% | 10,000,000 | 0.0% | 1.00% | +51.3% |
| Q4 2022 | $4,623,611 | -22.6% | 10,000,000 | 0.0% | 0.66% | -8.2% |
| Q3 2022 | $5,974,000 | -28.7% | 10,000,000 | -33.3% | 0.72% | +25.4% |
| Q2 2022 | $8,380,000 | -6.3% | 15,000,000 | 0.0% | 0.57% | +41.4% |
| Q1 2022 | $8,942,000 | -18.0% | 15,000,000 | 0.0% | 0.41% | -38.3% |
| Q4 2021 | $10,910,000 | -47.4% | 15,000,000 | 0.0% | 0.66% | -48.3% |
| Q3 2021 | $20,754,000 | -16.2% | 15,000,000 | 0.0% | 1.27% | -5.8% |
| Q2 2021 | $24,767,000 | – | 15,000,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |